Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Friberg Gregory R had 4,086 Biomarin Pharmaceutical Inc. shares withheld for tax (Form 4)
Traded Sep 30, 2026 · Filed Oct 1, 2026
On Sep 30, 2026, Friberg Gregory R (EVP, Chief R&D Officer) had 4,086 Biomarin Pharmaceutical Inc. shares withheld for tax at US$60.00 for US$245K, leaving 47,732 shares. Filed Oct 1, 2026 (Form 4).
- Withheld for tax
- 4,086 shares
- Price
- US$60.00
- Value
- US$245K
- Holding after
- 47,732 shares
- Trading plan
- No
- Role
- EVP, Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Shares withheld for tax | 4,086 | US$60.00 | 47,732 | Direct |
Source
Related
- Biomarin Pharmaceutical Inc.
- Friberg Gregory R
- Biomarin Pharmaceutical Inc. shareholders
- Form 4 · Friberg Gregory R · May 11, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026
- Form 4 · Ho Maykin · Jun 4, 2026